Back to RA CAPITAL MANAGEMENT, L.P.

RYTM
Showing 8 of 30 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in RHYTHM PHARMACEUTICALS INC

RA CAPITAL MANAGEMENT, L.P. holds 6.7M shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $579.8M as of 2026-Q1. RYTM represents 6.1% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$579.8M

Current Shares

6.7M

Total Value Change

+$330M

Total Shares Change

+582,425

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
6.7M
0.0%
$579.8M6.1%$89.56
0
2025-Q4
Increased
6.7M
+17.4%
$713.6M7.3%$106.76
72
2025-Q3
Increased
5.7M
+2.2%
$573.8M7.1%$100.64
62
2025-Q2
Decreased
5.6M
-8.6%
$351.4M5.9%$62.73
0
2025-Q1
Unchanged
6.1M
0.0%
$322.3M5.4%$54.80
0
2024-Q4
Unchanged
6.1M
0.0%
$340.6M4.5%$56.34
0
2024-Q3
Unchanged
6.1M
0.0%
$318.8M3.7%$51.35
0
2024-Q2
Increased
6.1M
+14.2%
$249.8M3.3%$41.06
64

Other major holders of RYTM: BlackRock, Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used